![Suraj Samtani: Our experience on Management of Lung Cancer with ALK mutation at ALKLINIC](https://oncodaily.com/pub/uploads/2024/08/suraj-e1724610071124-1280x775.jpeg)
Aug 26, 2024, 03:28
Suraj Samtani: Our experience on Management of Lung Cancer with ALK mutation at ALKLINIC
Suraj Samtani, Medical Oncologist at Harvard Medical School, shared on X:
“Honoured to share data and our experience on the management of Lung Cancer with ALK mutation at ALKLINIC in Sao Paulo with great colleagues around the world.”
Source: Suraj Samtani/X